Physician Assistant Program year 2024 Reported 2023–2024 Source: CMS Open Payments, 2026 publication

Andy Chorn

Physician Assistant Boise, ID Physician Assistant

NPI 1205111390 CMS profile 967024

7979 W Rifleman St, Boise, ID 83704

Open in the dashboard

General payments

$208

2 records reported · program years 2023–2024

Research payments

$0

Paid to them · None reported · program years 2023–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Andy Chorn of Boise, ID is reported in the CMS Open Payments database as having received $208 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 39th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $149 1
2023 General $59 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andy Chorn
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Andy Chorn were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Andy Chorn Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $59 $167 $52–$557 $160
2024 $149 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2023–2024
  1. Ortho Development Corporation $149 1 payment
  2. Medacta USA, Inc. $59 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2024
  1. Food and Beverage $208 2 payments
Products named General payments · program years 2023–2024
  1. GMK SPHERE $59 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

1,155

Median for Physician Assistant: 241

Drug cost

$12,678

Median for Physician Assistant: $4,110

Branded share of claims

4.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 16 $4,885
Celecoxib Generic 216 $3,987
Oxycodone Hcl Generic 287 $1,085
Omeprazole Generic 161 $951
Methocarbamol Generic 177 $652
Meloxicam Generic 96 $369
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 38 $199
Doxycycline Hyclate Generic 13 $166
Hydromorphone Hcl Generic 39 $143
Prednisone Generic 31 $102

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$36,581

Of which drugs: $1,381

Medicare patients

243

Average age 72

Services billed

635

159 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 55%
Diabetes 18%
Depression 16%
Ischemic heart disease 14%
Atrial fibrillation 14%
Osteoporosis 14%
Chronic kidney disease 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 37 $28

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record